Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Université Laval

$661,725.00

Isoprostanes and phospholipases A2: Roles in the pathophysiology of preeclampsia

EF 2016-17

Résumé
Pre-eclampsia is a complex pathology diagnosed during the second part of the pregnancy. This disorder is characterized by hypertension (high blood pressure), proteinuria (high protein levels in urine). This disorder occurs in 3 to 8% of all pregnancies. The only cure for preeclampsia is premature delivery, and this disorder is a leading cause of maternal and neonatal deaths. There are many evidences to support that oxidative stress plays an important role in pre-eclampsia. Oxidative stress is characterized by an excessive production of reactive oxygen derivatives that various antioxidant systems cannot eliminate, therefore leading to cell and tissue injuries. We have uncovered that fat oxidation is associated with pre-eclampsia in blood. The rate of production and elimination of oxidized fat will be investigated in blood and the placenta. In conclusion, this research project will improve our knowledge of the disease and determine the potential role of oxidized lipids as biochemical markers for the diagnosis of pre-eclampsia. This study will also help us to design new antioxidant and anti-inflammatory therapies.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
355926
Name
Bilodeau Jean-François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Isoprostanes and phospholipases A2: Roles in the pathophysiology of preeclampsia
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$661,725
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antioxidants; Fatty Acids; Isoprostanes; Lipid Peroxidation; Mass Spectrometry; Oxidative Stress; Phospholipases A2; Placenta; Preeclampsia; Thromboxane
Abstract
Pre-eclampsia is a complex pathology diagnosed during the second part of the pregnancy. This disorder is characterized by hypertension (high blood pressure), proteinuria (high protein levels in urine). This disorder occurs in 3 to 8% of all pregnancies. The only cure for preeclampsia is premature delivery, and this disorder is a leading cause of maternal and neonatal deaths. There are many evidences to support that oxidative stress plays an important role in pre-eclampsia. Oxidative stress is characterized by an excessive production of reactive oxygen derivatives that various antioxidant systems cannot eliminate, therefore leading to cell and tissue injuries. We have uncovered that fat oxidation is associated with pre-eclampsia in blood. The rate of production and elimination of oxidized fat will be investigated in blood and the placenta. In conclusion, this research project will improve our knowledge of the disease and determine the potential role of oxidized lipids as biochemical markers for the diagnosis of pre-eclampsia. This study will also help us to design new antioxidant and anti-inflammatory therapies.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Bilodeau, Jean-François
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $661,725~ $0~